15.1 Paediatric gynaecology
Prepubescent girls
Prepubescent gynaecology
Vulvovaginitis
This is the most common gynaecological problem in childhood, usually occurring in girls aged between 2 years and prior to the onset of puberty.1,2 Most vulvovaginitis in this age group is non-infectious in origin and results from irritation of the vaginal and vulval skin, particularly where there is contact between the labial surfaces.2,3 Factors that contribute to genital inflammation include the vaginal and vulval skin of children being thin and atrophic due to low oestrogens and therefore easily irritated. In addition, lack of protective labial hair and fat pads as well as moisture from wet swimming costumes, obesity and poor hygiene may play a role.2–4 Additionally, the presence of bowel flora, which is the normal flora in the atrophic vagina, may contribute to skin irritation and the other related common symptom of offensive smell.
Infectious vulvovaginitis is less common and is due to an overgrowth of one organism, for example Group A Streptococcus, Staphylococcus, enterococci and Escherichia coli. In this instance, profuse discharge is usually present with marked skin inflammation, often beyond the contact surfaces of the labia.3 Isolation of an organism that has strong sexual transmission, such as Neisseria gonorrhoeae or Chlamydia trachomatis, generally indicates sexual abuse or sexual activity and therefore warrants further investigation.3,4
Lichen sclerosis is an uncommon condition of unknown aetiology. It may present in childhood with vulval irritation, pruritus, dysuria or bleeding.1,2 Examination reveals pale atrophic patches on the labia and perineum. The patches can be extensive and coalesce, and with scratching lead to chronic inflammation and purpuric haemorrhage into the skin. The condition usually persists with intermittent exacerbations. Most resolve before puberty although some may continue to have problems into adult life.5
Candida is very uncommon in the prepubertal girl unless there has been significant antibiotic use or they are still in nappies.2,4 (Thrush thrives in an oestrogenised environment, not in the atrophic setting.) In this age group, recurrent or unexplained candida requires exclusion of diabetes mellitus or other causes of diminished immune function.
History
The child or parent/caregiver usually describe:
These symptoms often fluctuate in severity.
A general medical history is required, with specific history of the symptoms and their duration including nature of discharge as well as any previous treatments. Also important is past history of urinary tract infection, encopresis, constipation, enuresis, the presence of skin disorders, and any other illness, including antibiotic use in the previous 4 weeks. Although a history of perineal hygiene (e.g. wipe front to back, frequency of bathing, type of underwear/clothes, specific irritants, such as bubble baths or use of feminine hygiene sprays in the adolescent population, etc.) should also be established, there is limited evidence to support the role of this in the pathogenesis of vulvovaginitis.3 Where itch is the dominant symptom, pinworms should be considered and questions asked about family symptoms.
Examination
A general examination including sexual development is required. Perineal, vulval and introital examination may be required for the above conditions. Attempts must be made to ensure it is not a traumatic event for the child. The perineum is best examined either with the girl supine with heels together and knees flexed and hips abducted or in the lateral position with knees drawn up to the chest.6 Vaginal examination is inappropriate in paediatric patients and usually provides little further information. Specific external examination of the perineum usually reveals mucoid discharge and reddened introitus, particularly on the contact surfaces between the labia.
The presence of a profuse discharge or marked skin inflammation, especially if it extends beyond the contact surfaces of the labia, suggests an infectious cause. An offensive discharge can occur with vulvovaginitis or foreign body. A bloody discharge can occur with vulvovaginitis (particularly with Shigella or Group A streptococci).6 The presence of perianal excoriation suggests pinworm.
Investigations
Swabs are generally not required. If taken in mild cases, they usually reveal a growth of mixed coliforms.3 If discharge is visible or profuse or marked erythema is present, introital swabs should be taken for culture. Vaginal swabs are painful and distressing and are not required.
Management
Vulvovaginitis

Where itch is a dominant symptom consider:
Vaginal bleeding
Introduction
Vaginal bleeding in the prepubertal child is abnormal after 3–4 weeks of age.6
Causes of vaginal bleeding in the prepubertal girl can be classed as hormonal and non-hormonal.
Labial adhesions
Labial adhesions are seen in infancy, and usually resolve by about 8 years, although they may occasionally persist through to puberty when they will resolve around the time of menarche. The adhesion is not congenital, but it is acquired from a secondary adherence of the atrophic surfaces of the labia minora, presumably as a result of irritation.1,2
Labial adhesions are usually asymptomatic in children and do not need to be divided as long as the child is able to void. When symptoms occur they usually relate to difficulty with urination or pooling of urine behind fused labia, which results in irritation.1,2,5 Urinary tract infections are seldom a complication.5 Parents should be reassured that separation of the labia will occur when oestrogenisation commences as the child grows. Although it is possible to divide the adhesions with lateral traction this is frequently distressing for the child and the parents, and unnecessary. There is a considerable recurrence rate after this approach.5
Associated nappy rash or vulvovaginitis is managed as described above.
Adolescent gynaecology
Vaginal discharge
Introduction
Vaginal discharge in an adolescent female may be physiological, a symptom of vaginal or cervical infection or secondary to a vaginal foreign body. Under the influence of oestrogen there is an increase in the glycogen production by the vaginal epithelial cells, which supports the growth of lactobacilli in the vagina, which leads to lowering of the vaginal pH to 3.8–4.5. The acidic environment helps to inhibit the growth of bacteria seen in the prepubertal female. Oestrogen also influences the cervix, resulting in increased mucous production, which is largely responsible for the physiological vaginal discharge.8
History
Diagnosis can often be suspected from the history and the appearance of the discharge.
Management
Abnormal vaginal bleeding
Introduction
Abnormal vaginal bleeding may be caused by a complication of pregnancy, trauma, infection or it may be secondary to contraceptive use. The most common causes of heavy vaginal bleeding are anovulatory bleeding or an underlying haematological condition.11
Menstrual cycles in adolescents are often anovulatory due to the gradual maturation of the hypothalamic–pituitary–ovarian axis, which can take up to 5 years after the menarche.11–14 Anovulatory or dysfunctional uterine bleeding generally presents as irregular, often heavy, blood loss. Anovulatory bleeding may result from a relative deficiency of either oestrogen or progesterone. Relative oestrogen deficiency is more common in thin young women who have just commenced their menstrual cycles. The relative oestrogen deficiency results in a thin, atrophic endometrium, which can bleed profusely.
Menorrhagia, whether associated with ovulatory or anovulatory cycles, may be a marker of systemic illness. Up to 20% of patients admitted with menorrhagia have been found to have an underlying haematological disease, the most common of which is a coagulopathy, half of which are von Willebrand’s disease and the other half due to platelet problems or dysfunction – other factor deficiencies are very rare.11,14
Chronic untreated menorrhagia may also present with signs and symptoms of anaemia.
Investigations
A full blood count, iron studies and coagulation screen will assist in identifying anaemia, an underlying coagulopathy or haematological cause for the bleeding( although caution needs to be taken in interpreting these results as stress may result in apparent ‘normalising’ of the test results, particularly in von Willebrand’s disease11). A pregnancy test should also be performed.
Dilation and curettage is very rarely indicated for a diagnosis and is not a recognised treatment for dysfunctional uterine bleeding.15
Management
Oestrogens and progestins are generally used in the management of anovulatory bleeding. Suggested regimens vary with respect to the route of administration, the dose and the type of hormone used. Currently there is no convincing evidence in favour of any particular regimen.16
For both the acute and non acute bleed tranexamic acid should be used. This can be used in combination with hormonal approaches. If using progestogens first line, regimens include oral norethisterone 5–10 mg every 2 hours for four doses, followed by 5 mg two to three times a day for 14 days.8 Commencing the oral contraceptive pill once the bleeding has ceased may be sensible, as cessation of the progestogens will almost invariably result in bleeding recommencing.
Alternatively, treatment may include oral conjugated oestrogens 0.625–1.25 mg every 4–6 hours or oral oestradiol 1–2 mg every 4–6 hours until the bleeding stops, which is usually about 24 hours. The dose is then reduced to once or twice daily. Intravenous conjugated oestrogens are no longer available in Australia and have been associated with thromboembolic complications, consequently oral regimens are generally preferred.17 This approach is worth taking when progestogens have already been used and failed, but can be used first line. Again, the oral contraceptive pill should be commenced for ongoing control, particularly if there is a need to allow some time before further menses in the context of a low haemoglobin. Supplement with iron therapy.
Menorrhagia, in the absence of a coagulation disorder or other underlying pathology, can be treated with non-steroidal anti-inflammatory agents or tranexamic acid, which reduce the menstrual loss by 33% and 50% respectively,11,18 or, alternatively, low-dose oral contraceptive therapy.12
Pelvic pain
History
Investigations
A pregnancy test and a pelvic ultrasound are the most valuable tests for excluding pregnancy-related conditions. Ultrasound is the investigation of choice for the definition of masses and in the identification of ovarian cysts.23 If a congenital anomaly is suspected, information regarding the kidneys at the time of the ultrasound can be helpful.
Laparoscopy is reserved for pain that cannot be adequately explained or has failed to respond to appropriate treatments. Laparoscopy may be required to exclude torsion where a cyst is present combined with a suspicious history.21 It may also have a role in the investigation of chronic pelvic pain.
Management
Acknowledgement
The contribution of Sheila Bryan as author in the first edition is hereby acknowledged.
1 Mroueh J., Muram D. Common problems in paediatric gynaecology: New developments. Curr Opin Obstet Gynecol. 1999;11(5):463-466.
2 Fiorillo L. Therapy of paediatric genital diseases. Dermatol Ther. 2004;17:117-128.
3 Jaquiery A., Styianopoulos A., Hogg G., Grover S. Vulvovaginitis: Clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child. 1999;81:64-67.
4 Farrington P. Paediatric vulvo-vaginitis. Clin Obstet Gynaecol. 1997;40(1):135-140.
5 Fischer G. Vulval disease in pre-pubertal girls. Australas J Dermatol. 2001;42:225-236.
6 Quint E. Vaginal bleeding and discharge in the paediatric and adolescent age groups. In: Pearlman M., Tintinalli J., editors. Emergency care of the woman. New York: McGraw-Hill; 1998:395-407.
7 Grover S. Gynaecological conditions. In: Smart, editor. Paediatric handbook. 6th ed. Melbourne: Blackwell Science Asia; 2000:342-350.
8 Mackay E., Beischer N., Pepperell R., Wood C. Illustrated textbook of gynaecology, 2nd ed. London: WB Saunders; 2000.
9 Blake D.R., Fletcher K., Joshi N., Emans S.J. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Paediatr Adolesc Gynaecol. 2003;16(1):25-30.
10 Therapeutic Guidelines. Antibiotic Version 13. Therapeutics Guidelines Ltd; 2006.
11 Grover S. Bleeding disorders and heavy menses in adolescents. Curr Opin Obstet Gynecol. 2007;19:415-419.
12 Sandofilippo J.S., Lara-Torre E. Adolescent gynaecology. Obstet Gynaecol. 2009;113:935-947.
13 Apter D., Viinikka L., Vihko R. Hormonal pattern of adolescent menstrual cycles. J Clin Endocrinol Metab. 1978;47(5):944-954.
14 Claessens E.A., Cowell C.A. Acute adolescent menorrhagia. Am J Obstet Gynecol. 1981;139(3):277-280.
15 Duflos-Cohade C., Amandruz M., Thibaud E. Pubertal metrorrhagia. J Paediatr Adolesc Gynaecol. 1996;9(1):16-20.
16 Hickey M., Higham J., Fraser I.S. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation. In: Cochrane Review. The Cochrane Library. Oxford: Update software; 2003. Issue 3
17 Richlin S.S., Rock J.A. Abnormal uterine bleeding. In: Carpenter S.E.K., Rock J.A., editors. Paediatric and adolescent gynaecology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:207-224.
18 Prentice A. Fortnightly review: Medical management of menorrhagia. Br Med J. 1999;319:1343-1345.
19 Hann L.E., Hall D.A., Black E.B., Ferrucci J.T. Mittelschmerz. Sonographic demonstration. JAMA. 1979;241(25):2731-2732.
20 Ben-Ami M., Perlitz Y., Haddad S. The effectiveness of spectral and color Doppler in predicting ovarian torsion. A prospective stud. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):64-66.
21 Grover S. Pelvic pain in the female adolescent patient. Aust Fam Phys. 2006;35(11):850-853.
22 Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR. 2002;51(NoRR-6):32-36. 69–71
23 Arbel-Derowe Y., Tepper R., Rosen D.J., et al. The contribution of pelvic ultrasound to the diagnostic process in paediatric and adolescent gynaecology. J Paediatr Adolesc Gynaecol. 1997;10:3-12.
24 Sanfilippo J., Erb T. Evaluation and management of dysmenorrhoea in adolescents. Clin Obstet Gynecol. 2008;51(2):257-267.
25 Bolton P., Del Mar C., O’Connor V. Exercise for primary dysmenorrhoea (Protocol for a Cochrane Review). In: The Cochrane Library. Oxford: Update Software; 2003. Issue 3
26 Hemsel D.L., Ledger W.J., Martens M., et al. Concerns regarding the Centers for Disease Control’s published guidelines for pelvic inflammatory disease. Clin Infect Dis. 2001;32:103-107.